Skip to content
Back to feed
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyInterventionalTrial registry record – peer review not applicable

Repetitive Transcranial Magnetic Stimulation in Human Subjects

A study planned to evaluate the effect of Repetitive Transcranial Magnetic Stimulation (rTMS) on improving performance in the Timed 25-Foot Walk Test (T25FWT) in a sample of 70 human participants. The study was designed to be randomized and controlled with a follow-up of 12 to 18 weeks. However, no results have been posted yet.

Most relevant to
—
This plain-English summary was written by AI from a trial registry record and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.
Human efficacy
Not established from this source
Mechanism
Not reported
Evidence strength
No results yet
Outcome
Not reported

Why it matters

Investigating rTMS could contribute to understanding its potential role in improving mobility in patients, which is significant in conditions like multiple sclerosis.

What this does not prove

The study does not have results available, and no publication date is provided; planned enrollment and endpoints alone do not yield conclusive findings.

Next milestone

No next milestone was established from the available source.

Study facts
Study design
Interventional
Participants / samples
70 · planned enrolment
Randomised
Yes
Controlled
Yes
Primary endpoint met
Not reported
Relevant MS type
Not reported
Publication date
Not reported
Evidence reviewed
Trial registry record
Regulatory approval
Not reported
Research areas
Not classified
Biological target
Not reported
Pathway
Not reported
Population
people; ages from 18 Years to 70 Years; sex All
Size of effect
Not reported
Secondary endpoints
Not reported
MRI endpoints
Not reported
Biomarkers
Not reported
Safety
Not reported

Original sources

Supporting passages (14)
study phasePhase: Not applicable
study designStudy type: Interventional
subjectsParticipants: people; ages from 18 Years to 70 Years; sex All
sample sizeEnrollment: 70 participants (estimated)
randomizedAllocation: Randomized
controlledArm types: Active comparator; Sham comparator
peer reviewedTrial registry record.
primary endpointPrimary endpoints: Improvement of T25FWT (Timed 25-Foot Walk Test)
follow upFollow-up: 18 weeks; 12 weeks
limitationsPublication date: unknown. No results are posted. Planned enrolment and endpoints are not findings.
populationParticipants: people; ages from 18 Years to 70 Years; sex All
findingsTrial registry record. Publication date: unknown. No results are posted. Planned enrolment and endpoints are not findings.
interventionInterventions: Repetitive Transcranial Magnetic Stimulation
sample size basisEnrollment: 70 participants (estimated)

AI assessment, not yet reviewed by a person · version 3 · Community votes are separate from evidence review.

0

Discussion 0 comments

Log in or join to comment.